Has Christopher Bowman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,740 in general payments to Christopher Bowman, MD across 402 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Bowman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Bowman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Bowman, MD

Internal Medicine · Dunbar, WVNPI 1649231606

Payments from drug & device makers

$6,740in general payments, 2019–2025

Across 402 payments — averaging $16.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$983
Lilly USA, LLC$664
AstraZeneca$640
AbbVie$622
Bayer$440
Dexcom, Inc.$384
plus $3K from 39 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	60	$983
Lilly USA, LLC	37	$664
AstraZeneca	22	$640
AbbVie	40	$622
Bayer	28	$440
Dexcom, Inc.	35	$384
Merck	15	$237
Amgen(2 entities)	12	$222
Boehringer Ingelheim	14	$216
Johnson & Johnson	15	$209
Novartis	13	$204
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	13	$195
Sanofi-aventis U.S. LLC	12	$185
Pfizer	8	$160
GSK	9	$143
Otsuka America Pharmaceutical, Inc.	7	$131
Amarin Pharma, Inc.	9	$126
Sumitomo Pharma America, Inc.	5	$100
Abiomed	3	$82
Biohaven Pharmaceutical Holding Company Ltd.	4	$69
Phathom Pharmaceuticals, Inc.	5	$66
Paratek Pharmaceuticals, Inc.	3	$59
Lundbeck LLC	3	$58
Recor Medical Inc	2	$53
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$40
Astellas Pharma US Inc	2	$36
Takeda Pharmaceuticals U.S.A., Inc.	2	$36
Neurelis, Inc.	2	$36
Abbott	2	$32
Medtronic	1	$29
Smith+Nephew	2	$28
Teva Pharmaceuticals USA, Inc.	2	$26
Kowa Pharmaceuticals America, Inc.	1	$24
Esperion Therapeutics, Inc.	1	$23
Ironshore Pharmaceuticals Inc.	1	$21
Vanda Pharmaceuticals Inc.	1	$19
Biohaven Pharmaceuticals, Inc.	1	$19
Xeris Pharmaceuticals, Inc.	1	$18
Mylan Specialty L.p.	1	$17
Evoke Pharma, Inc.	1	$16
Vertex	1	$16
Ultragenyx Pharmaceutical Inc.	1	$14
E.r. Squibb & Sons, L.L.C.	1	$14
Exact Sciences	1	$14
Genentech USA, Inc.	1	$12

How this compares

$6,740 in reported general payments places this provider in the 90th percentile of 573 internal medicine providers in West Virginia.

See all internal medicine providers in West Virginia →

Medicare billing

Part B allowed, 2024

$157,971

Medicare patients

367

Services billed

1,760

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Dunbar

John LillyDunbar$9K
Jeffrey HolmesDunbar$9K
Ward PaineMorgantown$5.1M
William ChapmanCharleston$1.7M
Mustafa AwiliHuntington$906K
David PickeringParkersburg$694K
Laura DavissonMorgantown$118K
Michael BrumageClendenin$87K
Govind PatelFairmont$59K
Lynn SmithLewisburg$31K

See the full list for West Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →